Aviv Regev: The Computational Biologist Remaking Drug Discovery At Genentech

 
• By David Wild
  
Aviv Regev, head of Early Research and Development, Genentech
Aviv Regev, head of Early Research and Development, Genentech (Genentech)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from C-Suite Speaks

More from Leadership